NCT00127842View on ClinicalTrials.gov

REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2005

Study Completion Date

September 30, 2009

Conditions
Psoriatic Arthritis
Interventions
DRUG

Etanercept

Administered according to the product monograph by subcutaneous (SC) injection

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Amgen

INDUSTRY